Nasoethmoidal meningocele in a child presenting bilateral congenital cystic adenomatoid malformation: Evidence for a new entity or consequence of gestational exposures?

BACKGROUND Nasoethmoidal meningocele is considered an uncommon type of cephalocele, and congenital cystic adenomatoid malformation (CCAM) is a rare lung disorder characterized by overgrowth of the terminal bronchioles. CASE We report the unusual association between a nasoethmoidal meningocele and CCAM type II in a fetus exposed to valproic acid and misoprostol. The mother was an 18-year-old woman on her first pregnancy. She had a history of absence seizures since she was 5 years old. She took valproic acid from the beginning of the gestation until the end of the third month. At the end of the third month, she attempted interruption of her pregnancy using misoprostol. The fetal nasoethmoidal meningocele and CCAM type II were identified through morphological ultrasound examination and magnetic resonance imaging. A genome-wide study detected one copy number variation classified as rare, entirely contained into the SPATA5 gene. However, it does not seem to be associated to the clinical findings of the patient. CONCLUSION To our knowledge, there is only one case reported in the literature showing the same association between a nasoethmoidal meningocele and CCAM. Thus, the malformations observed in our patient may be related to the gestational exposures. Also, we cannot rule out that the patient may present the same condition characterized by a cephalocele and CCAM described by some authors, or even an undescribed entity, because some hallmark features, such as laryngeal atresia and limb defects, were not observed in our case. Further reports will be very important to better understand the associations described in our study.

[1]  D. Beghin,et al.  Birth defects after exposure to misoprostol in the first trimester of pregnancy: prospective follow-up study. , 2013, Reproductive toxicology.

[2]  Zhi-Ping Wang,et al.  Maternal smoking during pregnancy and neural tube defects in offspring: a meta-analysis , 2013, Child's Nervous System.

[3]  Rebecca M Baron,et al.  Maternal smoking and the retinoid pathway in the developing lung , 2012, Respiratory Research.

[4]  M. Nöthen,et al.  Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata , 2011, European Journal of Human Genetics.

[5]  G. Koren,et al.  Is carbamazepine safe to take during pregnancy? , 2012, Canadian family physician Medecin de famille canadien.

[6]  A. Hackshaw,et al.  Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls , 2011, Human reproduction update.

[7]  Rosa Liascovich,et al.  Efecto teratogénico del misoprostol: un estudio prospectivo en Argentina , 2011 .

[8]  H. Dutta,et al.  Anterior encephaloceles in children of Assamese tea workers. , 2010, Journal of neurosurgery. Pediatrics.

[9]  A. Ornoy Valproic acid in pregnancy: how much are we endangering the embryo and fetus? , 2009, Reproductive toxicology.

[10]  K. Lakhoo,et al.  Congenital lung lesions: classification and concordance of radiological appearance and surgical pathology , 2008, Pediatric Surgery International.

[11]  K. Liechty,et al.  Postnatal management and outcome of prenatally diagnosed lung lesions , 2008, Prenatal diagnosis.

[12]  R. Azizkhan,et al.  Congenital cystic lung disease: contemporary antenatal and postnatal management , 2008, Pediatric Surgery International.

[13]  A. R. Arshad,et al.  Frontoethmoidal Encephalocele: Treatment and Outcome , 2008, The Journal of craniofacial surgery.

[14]  S. Langlois,et al.  Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. , 2007, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[15]  R. Wickstrom Effects of nicotine during pregnancy: human and experimental evidence. , 2007 .

[16]  M. Yerby Clinical Care of Pregnant Women with Epilepsy: Neural Tube Defects and Folic Acid Supplementation , 2003 .

[17]  E. Mark,et al.  Cystic adenomatoid change is common to various forms of cystic lung diseases of children: a clinicopathologic analysis of 10 cases with emphasis on tracing the bronchial tree. , 2002, Archives of pathology & laboratory medicine.

[18]  J. Stocker Congenital pulmonary airway malformation : a new name and expanded classification of congenital cystic adenomatoid malformation of the lung , 2002 .

[19]  E. Perucca,et al.  Pharmacological and Therapeutic Properties of Valproate , 2002, CNS drugs.

[20]  A. Trusen,et al.  Bilateral cystic adenomatoid lung malformation type III – a rare differential diagnosis of pulmonary hypertension in neonates , 2002, Journal of perinatal medicine.

[21]  C. Rodeck,et al.  Laryngeal atresia, encephalocele, and limb deformities (LEL): a possible new syndrome , 2001, Journal of medical genetics.

[22]  L. Ben‐Sira,et al.  The postnatal management of congenital cystic adenomatoid malformation. , 2001, The Israel Medical Association journal : IMAJ.

[23]  C. Kozma Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. , 2001, American journal of medical genetics.

[24]  M. Kulesz-Martin,et al.  SPAF, a new AAA-protein specific to early spermatogenesis and malignant conversion , 2000, Oncogene.

[25]  M. Khoury,et al.  Neural-tube defects. , 1999, The New England journal of medicine.

[26]  E. Castilla,et al.  Teratogenicity of misoprostol: data from the Latin-American Collaborative Study of Congenital Malformations (ECLAMC) , 1994, American journal of medical genetics.

[27]  S. Clarren,et al.  Verification of the fetal valproate syndrome phenotype. , 1988, American journal of medical genetics.

[28]  J. Popkin,et al.  Fetus with asymmetric parietal encephalocele, and hydrops secondary to laryngeal atresia. , 1987, American journal of medical genetics. Supplement.

[29]  A. Hunter,et al.  Neural tube defects in Eastern Ontario and Western Quebec: demography and family data. , 1984, American journal of medical genetics.

[30]  R. Drake,et al.  Cystic and congenital lung disease in the newborn. , 1978, Perspectives in pediatric pathology.